| Trial ID: | L4651 |
| Source ID: | NCT03907423
|
| Associated Drug: |
Rosuvastatin10 Mg Tablet
|
| Title: |
Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Rosuvastatin10 mg tablet|DRUG: Placebo Oral Tablet
|
| Outcome Measures: |
Primary: serum levels of fetuin A, Fetuin-A has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome., three months|serum levels of Sortilin, Sortilin is involved in lipid metabolism, promotes the development of atherosclerosis, and possibly becomes a potential therapeutic target for atherosclerosis treatment., three months |
|
| Sponsor/Collaborators: |
Sponsor: Rehab Werida
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
70
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2019-04-01
|
| Completion Date: |
2021-01-31
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-14
|
| Locations: |
Damanhour Medical National Institute, Damanhūr, N/A = Not Appُlicable, 31527, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT03907423
|
